BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
34.95
+0.03 (0.09%)
Sep 11, 2026, 4:00 PM EDT - Market closed

BioLife Solutions Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
57.98-4.6-20.18-68-139.81-8.91
Depreciation & Amortization
5.154.698.6612.37.5812.87
Other Amortization
---0.010.020.12
Loss (Gain) From Sale of Assets
0.180.520.721.231.521.09
Asset Writedown & Restructuring Costs
---15.49--
Loss (Gain) From Sale of Investments
-1.61-1.723.6-1.26-1.14-
Stock-Based Compensation
21.6422.9930.9233.2525.3313.96
Other Operating Activities
-39.5417.460.36-6.97-6.34-21.46
Change in Accounts Receivable
-1.540.26-2.915.35-10.75-10.13
Change in Inventory
-7.96-1.270.78-8.55-6.560.11
Change in Accounts Payable
-0.8-2.090.03-8.430.412.02
Change in Other Net Operating Assets
-4.57-5.822.323.091.995.74
Operating Cash Flow
16.8820.128.43-12.5-8.49-4.59
Operating Cash Flow Growth
8.59%138.58%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-9.24-10.36-5.3-11.24-13.92-14.76
Sale of Property, Plant & Equipment
-----0.01
Cash Acquisitions
-----1.56
Sale (Purchase) of Intangibles
-0.12--0.3---
Investment in Securities
-22.39-74.473.529.07-44.2-
Other Investing Activities
23.5213.360.39---
Investing Cash Flow
-8.24-71.5458.317.84-58.12-13.19

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----27.31
Long-Term Debt Issued
----201.55
Total Debt Issued
----2028.86
Short-Term Debt Repaid
------31.54
Long-Term Debt Repaid
--10-6.61-0.5-2.16-0.21
Total Debt Repaid
-10-10-6.61-0.5-2.16-31.75
Net Debt Issued (Repaid)
-10-10-6.61-0.517.84-2.89
Issuance of Common Stock
0.190.020.210.750.321.42
Other Financing Activities
-0.05-0.94-0.380.34-1.84-1.3
Financing Cash Flow
-16.54-10.92-6.7810.5916.32-2.78

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
---0.04-0.11-0.02
Net Cash Flow
-7.91-62.3559.9515.97-50.4-20.59

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
7.639.753.14-23.74-22.41-19.35
Free Cash Flow Growth
-29.73%210.94%----
Free Cash Flow Margin
7.16%10.13%4.20%-34.90%-29.39%-16.24%
Free Cash Flow Per Share
0.150.200.07-0.54-0.52-0.50
Levered Free Cash Flow
4.6612.4444.8315.5-6.54-13.4
Unlevered Free Cash Flow
4.6612.4445.3116.37-6.38-13.22

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.390.761.611.930.59-
Change in Working Capital
-14.88-8.910.231.47-14.91-2.26
SEC Filings: 10-K · 10-Q